Back to mobile site

Jefferies Reiterates Buy Rating on Disc Medicine (IRON)

November 20, 2025 4:10 AM EST Send to a Friend
Jefferies analyst Roger Song reiterated a Buy rating and $127.00 price target on Disc Medicine (NASDAQ: IRON)The analyst comments "Bottom ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login